Predictors of surgical site infection after liver resection: a multicentre analysis using National Surgical Quality Improvement Program data.

Predictors of surgical site infection after liver resection: a multicentre analysis using National Surgical Quality Improvement Program data.

[Anonymous].  2012.  Predictors of surgical site infection after liver resection: a multicentre analysis using National Surgical Quality Improvement Program data.. HPB : the official journal of the International Hepato Pancreato Biliary Association. 14(2):136-41.

PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.

The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.

Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease.

PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation.

The role of bridging therapy in hepatocellular carcinoma.

Molecular therapies in hepatocellular carcinoma: what can we target?

Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways.

Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535.

Direct intranodal lymphangiography for recurrent chylous ascites following liver-kidney transplantation.

Direct intranodal lymphangiography for recurrent chylous ascites following liver-kidney transplantation.

[Anonymous].  2014.  Direct intranodal lymphangiography for recurrent chylous ascites following liver-kidney transplantation.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 20(10):1275-6.